ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,530Medicare Part D Prescriptions Filled, Including Refills

Rank: 12 out of 1111

$1.62M Total Retail Price of All Prescriptions

Rank: 11 out of 1111

589 Patients Receiving at Least One Drug in Part D
57%Patients 65 Years and Older
88% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 589 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

24% of this provider’s 589 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

3% of this provider’s 12,702 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

43 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
OMEPRAZOLE 1,027 485 1 4
HYDROCODONE-ACETAMINOPHEN 708 400 S3 2 1
NAMENDA 690 271 3 31
RANITIDINE HCL 541 220 4 29
POLYETHYLENE GLYCOL 3350 534 189 5 45
LEVOTHYROXINE SODIUM 501 283 6 3
POTASSIUM CHLORIDE 495 299 7 9
METFORMIN HCL 468 247 8 8
LISINOPRIL 451 301 9 2
DONEPEZIL HCL 424 356 10 25
CITALOPRAM HBR 419 188 11 14
FUROSEMIDE 417 317 12 6
SIMVASTATIN 414 253 13 5
ESCITALOPRAM OXALATE 370 89 14 78
TAMSULOSIN HCL 369 170 15 28
RISPERIDONE 309 205 16 60
FAZACLO 286 0 17 219
ZOLPIDEM TARTRATE 279 195 18 16
GABAPENTIN 276 136 19 10
LOVASTATIN 272 135 20 41
MELOXICAM 261 170 21 18
TORSEMIDE 251 146 22 118
CLONIDINE HCL 221 71 23 42
TRIAMTERENE-HCTZ 219 119 24 80
LAMOTRIGINE 218 0 25 172
TRAMADOL HCL 215 135 26 13
METOPROLOL TARTRATE 215 152 26 12
DIVALPROEX SODIUM 212 74 28 82
AMLODIPINE BESYLATE 209 155 29 7
CLOZAPINE 199 0 30 181
ALENDRONATE SODIUM 198 102 31 35
QUETIAPINE FUMARATE 192 113 32 76
GLYBURIDE 185 92 R 33 59
SERTRALINE HCL 175 98 34 24
ATORVASTATIN CALCIUM 169 73 35 15
TRAZODONE HCL 163 97 36 32
SINGULAIR 159 60 37 112
LEVETIRACETAM 158 17 38 111
METOCLOPRAMIDE HCL 154 92 39 130
ENALAPRIL MALEATE 149 95 40 56
HYDROCHLOROTHIAZIDE 146 78 41 11
CLOPIDOGREL 146 134 41 30
OLANZAPINE 143 58 43 117
IBUPROFEN 143 66 43 66
MEDROXYPROGESTERONE ACETATE 143 24 43 280
DOXYCYCLINE HYCLATE 139 49 46 113
LANTUS 139 42 46 46
CARVEDILOL 136 61 48 21
PROPRANOLOL HCL 136 51 48 124
FLUTICASONE PROPIONATE 132 34 50 27
KLOR-CON M20 132 27 50 79
BYSTOLIC 130 92 52 133
VERAPAMIL ER 129 76 53 100
LEVOTHROID 127 43 54 262
DIVALPROEX SODIUM ER 127 32 54 171
LITHIUM CARBONATE 126 0 56 250
MIRTAZAPINE 120 68 57 52
AZITHROMYCIN 113 54 58 39
PAROXETINE HCL 112 68 59 55
METHYLPREDNISOLONE 110 49 60 93
WARFARIN SODIUM 108 58 61 19
FENTANYL 106 84 S2 62 65
MONTELUKAST SODIUM 105 35 63 206
FLUDROCORTISONE ACETATE 104 69 64 266
BACLOFEN 103 65 65 119
SPIRIVA 102 24 66 53
ATENOLOL 102 80 66 22
FLUOXETINE HCL 101 33 68 44
PINDOLOL 100 0 69 360
CARISOPRODOL 99 25 R 70 54
EXELON 99 82 70 121
MEGESTROL ACETATE 96 88 R 72 103
LEVOFLOXACIN 94 64 73 88
LISINOPRIL-HYDROCHLOROTHIAZIDE 92 43 74 23
SULFAMETHOXAZOLE-TRIMETHOPRIM 90 52 75 71
OXYBUTYNIN CHLORIDE ER 90 55 75 114
OXYBUTYNIN CHLORIDE 87 52 77 110
AMANTADINE 86 23 78 267
ALLOPURINOL 85 62 79 36
AGGRENOX 85 43 79 182
NOVOLOG 84 56 81 104
PLAVIX 83 72 82 49
PREDNISONE 82 30 83 48
NEXIUM 81 29 84 26
CYCLOBENZAPRINE HCL 80 16 R 85 37
LACTULOSE 79 31 86 166
OXYCODONE HCL-ACETAMINOPHEN 78 23 S2 87 86
JANUVIA 76 21 88 75
NAPROXEN 75 37 89 85
PROAIR HFA 74 23 90 38
LEXAPRO 73 14 91 208
SANTYL 72 47 92 179
FAMOTIDINE 70 58 93 77
DOXAZOSIN MESYLATE 70 35 93 87
SPIRONOLACTONE 70 53 93 83
CARBAMAZEPINE 69 17 96 196
LYRICA 68 34 97 62
SEROQUEL 68 40 97 170
ZETIA 68 33 97 109
BUPROPION XL 67 0 100 210
NITROFURANTOIN MONO-MACRO 67 54 100 149
TRIAMCINOLONE ACETONIDE 64 35 102 128
TERAZOSIN HCL 64 33 102 127
ROPINIROLE HCL 64 34 102 68
SUCRALFATE 64 38 102 125
ISOSORBIDE MONONITRATE ER 63 58 106 73
DETROL LA 63 16 106 139
TIZANIDINE HCL 62 42 108 91
TOPIRAMATE 62 0 108 177
AMITRIPTYLINE HCL 62 19 R 108 64
OXYCODONE HCL 61 35 S2 111 69
MUPIROCIN 61 51 111 154
PHENYTOIN SODIUM EXTENDED 61 43 111 126
HALOPERIDOL 58 12 114 180
CIPROFLOXACIN HCL 58 30 114 58
LOSARTAN POTASSIUM 55 14 116 34
METHOTREXATE 54 36 117 284
PROCHLORPERAZINE MALEATE 54 26 117 405
DESMOPRESSIN ACETATE 54 0 117 405
PANTOPRAZOLE SODIUM 53 21 120 50
IPRATROPIUM-ALBUTEROL 52 41 121 161
DIGOXIN 51 47 122 47
DIOVAN HCT 51 39 122 94
EVISTA 51 51 122 148
AMLODIPINE BESYLATE-BENAZEPRIL 50 44 125 67
ACETAMINOPHEN-CODEINE 50 36 S3 125 140
ABILIFY 50 19 125 123
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 3, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.